Tips from UW Health’s CMIO

The latest stories trending on MedCity News.

Editor's Pick

Top Story Don't Let the Floor Fall Out From Under Healthcare AI: Tips from UW Health's CMIO Without trust, the rapid adoption of AI in healthcare could stall, pointed out Joel Gordon, UW Health's chief medical information officer. He urged healthcare leaders to focus less on flashy rollouts and more on governance, collaboration, and meaningful metrics to ensure AI delivers lasting value. Sponsored Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options Presented by Faserna FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.  Learn more. INVEST Chicago Starts Tuesday, Get Your Ticket Now! INVEST 2025 Chicago - "Where Capital Meets Innovation." Join us May 20-21 at Willis Tower for two days packed with the latest healthcare insights, startup pitches, and unparalleled networking opportunities. Reserve Your Ticket

Featured News

Sprinter Health Raises $55M to Expand Home Health Services for Health Plans Sprinter Health's $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of the University of California, Google Ventures and Accel. BioMarin's $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease Inozyme Pharma's main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The Affordable Care Act's Lasting Impact On Healthcare Marketing Perhaps the most significant health policy of our time, it revolutionized coverage and access, as well as the way healthcare companies communicated. With its future uncertain, now is the time to look back on how it shaped a new era of healthcare marketing strategy and messaging. Driving Synthetic Biology Forward Through Adoption of Technology Enabling Rapid DNA and mRNA Synthesis Breakthroughs in synthetic biology could help accelerate advances in applications from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products.

Video   Adding Up the Costs of Medicare Advantage Proponents of Medicare Advantage say that these plans are cost effective and help seniors pay less. However, the Medicare Payment Advisory Commission (MedPAC) — which advises Congress on Medicare policies — recently released a report showing that in 2025, CMS will have spent $84 million more on Medicare Advantage enrollees than if those same individuals were enrolled in traditional Medicare. Still, many seniors say that Medicare Advantage plans suit them better because of low premiums and out-of-pocket costs. So how does this all add up? The government is paying more for Medicare Advantage enrollees, yet these same enrollees are paying less — who makes up the difference?

Sponsored The Top Surgical Instruments Needed for Extractions Presented by ProDentUSA Discover what tools are essential for efficient, safe surgical extractions in today's health care landscape, from elevators to forceps and beyond. Learn More

Resources

MedCity Pivot: How Veradigm Aims to Close the Information Gap Megan Zakrewsky, vice president of product at Veradigm talks about how the company is utilizing tech among providers, payers and patients. Watch now!

MedCity News • PO Box 901 • New York, NY unsubscribe